Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects

Individual participant data (IPD) from oncology clinical trials is invaluable for identifying factors that influence trial success and failure, improving trial design and interpretation, and comparing pre-clinical studies to clinical outcomes. However, the IPD used to generate published survival cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Plana, Deborah, Fell, Geoffrey, Alexander, Brian M., Palmer, Adam C., Sorger, Peter K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847344/
https://www.ncbi.nlm.nih.gov/pubmed/35169116
http://dx.doi.org/10.1038/s41467-022-28410-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847344/
https://www.ncbi.nlm.nih.gov/pubmed/35169116
http://dx.doi.org/10.1038/s41467-022-28410-9

Ejemplares similares